About Aratana
Aratana is a company based in United States founded in 2010 was acquired by Elanco in April 2019. Aratana has raised $47 million across 6 funding rounds from investors including Elanco, Square 1 Bank and Oxford Finance. Aratana has completed 2 acquisitions, including Okapi Sciences and Vet Therapeutics.
- Headquarter United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$47 M (USD)
in 6 rounds
-
Latest Funding Round
$40 M (USD), Debt – Conventional
Oct 16, 2015
-
Investors
Elanco
& 8 more
-
Employee Count
Not available
-
Investments & Acquisitions
Okapi Sciences
& 1 more
-
Acquired by
Elanco
(Apr 26, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Aratana
Aratana has successfully raised a total of $47M across 6 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $40 million completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Aratana
Aratana has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Elanco, Square 1 Bank and Oxford Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt firm focused on the life sciences sector
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Aratana
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aratana
Aratana has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Okapi Sciences and Vet Therapeutics.
Investment portfolio details for Aratana
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Antibody-based therapies for companion animal cancer treatment are developed.
|
Locked | Locked | 2009 | Locked | |
|
Limited information available
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for Aratana
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Aratana
Detailed financials for Aratana
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aratana Comparisons
Peer comparison for Aratana
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aratana
Detailed competitors of Aratana
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aratana
Complete news archive for Aratana
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aratana
Aratana was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Aratana is headquartered in United States.
Aratana is a funded company, having raised a total of $47M across 6 funding rounds to date.
Aratana Therapeutics was founded in 2010 in the United States as a developer of therapeutics for companion animals. Drugs in development stages are targeted at alleviating pain and inflammation from osteoarthritis in dogs and cats. Additional medicines are being created to address inappetence, cancer, and viral infections. Operations focus on advancing these treatments within the pet healthcare sector.
Aratana has made 2 acquisitions, including Okapi Sciences, and Vet Therapeutics.
Aratana has 9 investors. Key investors include Elanco, Square 1 Bank, Oxford Finance, European Union, and Kauffman Foundation.